2020
DOI: 10.1080/1120009x.2020.1761638
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of fosfomycin combined with vancomycin against vancomycin-resistant coagulase negative staphylococci

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 63 publications
0
3
0
Order By: Relevance
“…In Germany, beta-lactam antibiotics are often used as empiric therapy for VO, since the rate of methicillin-resistant S. aureus (MRSA) is less than 10% [23]. Due to the high rate of resistance of CoNS to oxacillin and other beta-lactams, as a result such empiric therapy would likely lead to higher treatment failure rates in SIVO [24,25].…”
Section: Discussionmentioning
confidence: 99%
“…In Germany, beta-lactam antibiotics are often used as empiric therapy for VO, since the rate of methicillin-resistant S. aureus (MRSA) is less than 10% [23]. Due to the high rate of resistance of CoNS to oxacillin and other beta-lactams, as a result such empiric therapy would likely lead to higher treatment failure rates in SIVO [24,25].…”
Section: Discussionmentioning
confidence: 99%
“…S. warneri [253][254][255] and S. capitis [256,257] have also joined the list with several isolates resistant to vancomycin, generating outbreaks especially in neonatal units, where S. epidermidis resistant isolates are also frequently found [258]. Fortunately, vancomycin remains an effective antibiotic against most of the CoNS isolates [189,222,245,259], being on the top list of antibiotics used to fight these infections, either alone or in combination with other antibiotics as cefazolin [209], rifampicin [213,260], and fosfomycin [261], among others. Rifampicin is also frequently used to treat staphylococcal infections; however, this antibiotic is associated with the rapid development of resistance when used alone and, as such, it should be used as part of a combined therapy [262][263][264].…”
Section: Resistance To Other Antibioticsmentioning
confidence: 99%
“…Several studies have reported that over 90% of CoNS are resistant to penicillin, 64.2% to 93.6% of CoNS are resistant to methicillin, and all CoNS are susceptible to vancomycin ( 6 9 ). In other studies, vancomycin- and linezolid-resistant CoNS have occasionally been reported ( 10 12 ). The trends are not favorable.…”
Section: Introductionmentioning
confidence: 86%